Combined anticancer drug sensitivity-determining marker

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9733256
SERIAL NO

14379945

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

To provide an anti-cancer agent sensitivity determination marker, which marker can determine whether or not the patient has a therapeutic response to the anti-cancer agent, and novel cancer therapeutic means employing the marker.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KEIO UNIVERSITYTOKYO 108-8345
KABUSHIKI KAISHA YAKULT HONSHA1-10-30 KAIGAN MINATO-KU TOKYO 1058660

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Nishimuta, Akito Shinjuku-ku, JP 8 13
Takahashi, Hiroyuki Minato-ku, JP 707 15645
Tanigawara, Yusuke Shinjuku-ku, JP 15 31
Tsuzaki, Junya Shinjuku-ku, JP 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 15, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 15, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00